Home › NDC Lookup › RxCUI directory › RxCUI 1487363

1 ML glatiramer acetate 40 MG/ML Prefilled Syringe [Copaxone] — RxCUI 1487363

RxNorm drug concept · Semantic branded drug
RxCUI 1487363 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1487363
Official name1 ML glatiramer acetate 40 MG/ML Prefilled Syringe [Copaxone]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as1 ML Copaxone 40 MG/ML Prefilled Syringe; Copaxone 40 MG in 1 ML Prefilled Syringe
FDA products mapped2
Package NDCs mapped3
Reported Medicaid activity (SDUD)7,340 prescriptions · 35 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Glatiramer Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's a treatment for relapsing forms of multiple sclerosis (MS) in adults. That includes a first episode that might signal MS (called clinically isolated syndrome), the classic rel...
  • What exactly is glatiramer acetate used for?
  • Yes, where you inject absolutely matters. You inject under the skin — never into a vein — and you should rotate your injection sites every single time. Good spots include your uppe...
  • How do I give myself the injection, and does it matter where I inject?
📖 Read our full Glatiramer Injection guide →

🕸️ Concept Web — How 1 ML glatiramer acetate 40 MG/ML Prefilled Syrin... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 1 ML glatiramer acetate 40 MG/ML Prefilled Syringe [Copaxone] RxCUI 1487363

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Glatiramer 214582
    • Glatiramer acetate 84375
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Copaxone 135779
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Glatiramer Prefilled Syringe 727577
    • Glatiramer acetate Prefilled Syringe 2648324
    • Glatiramer Injectable Product 1165202
    • Glatiramer acetate Injectable Product 2659780
    • Glatiramer Prefilled Syringe [Copaxone] 727580
    • Glatiramer acetate Prefilled Syringe [Copaxone] 2658501
    • Copaxone Injectable Product 1168791
    • Prefilled Syringe 721656
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 1 ML glatiramer acetate 40 MG/ML Prefilled Syringe SCD · 1487361
  • Glatiramer acetate 40 MG/ML SCDC · 1487360
  • Glatiramer Prefilled Syringe SCDF · 727577
  • Glatiramer acetate Prefilled Syringe SCDFP · 2648324
  • Glatiramer Injectable Product SCDG · 1165202
  • Glatiramer acetate Injectable Product SCDGP · 2659780

Brand-Name Concepts

  • Glatiramer acetate 40 MG/ML [Copaxone] SBDC · 1487362
  • Glatiramer Prefilled Syringe [Copaxone] SBDF · 727580
  • Glatiramer acetate Prefilled Syringe [Copaxone] SBDFP · 2658501
  • Copaxone Injectable Product SBDG · 1168791
  • Copaxone BN · 135779

📦 FDA Products & Package NDCs

2 products · 3 package NDCs
3 package NDCs map to RxCUI 1487363 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68546-0317-30 30 BLISTER PACK in 1 CARTON (68546-317-30) / 1 SYRINGE, GLA... Copaxone Teva Neuroscience, Inc. 2008-04-28
68546-0325-06 6 BLISTER PACK in 1 CARTON (68546-325-06) / 1 SYRINGE, GLAS... Copaxone Teva Neuroscience, Inc. 2014-01-29
68546-0325-12 12 BLISTER PACK in 1 CARTON (68546-325-12) / 1 SYRINGE, GLA... Copaxone Teva Neuroscience, Inc. 2014-01-29
Observed labelers: Teva Neuroscience, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.